Jul. 28 at 3:55 PM
$TSLA $NVDA $META $AGX Argan Outperforms NVDA, TSLA, MSFT, and All Mag 7 — New Breakout Ahead
While NVDA, TSLA, MSFT, and other Mag 7 stocks dominate headlines, AGX has surged 204% over the past 12 months—far outpacing NVDA (+54%) and AAPL (-2%). Now on the IBD Leaderboard watchlist, AGX is building a new buy point.
A data-center infrastructure play, Argan posted 176% EPS growth and 23% revenue growth in Q2. It holds a top-tier 99 Composite Rating and joins NVDA and META as a top mutual fund buy, signaling strong institutional demand.